Losartan carboxylic acid

N/A

Report date: 2023/11/30 16:56:46

Base Information

Drug NameLosartan carboxylic acid
Drug Alias NameCarboxylosartanEXP-3174E-3174
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor antagonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsReperfusion InjuryArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme CorpBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability CompanyMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A